Key result
Bivalirudin was successfully used as an anticoagulant in a 2-month old infant with antithrombin deficiency undergoing stent placement.
Why the study?
Does bivalirudin provide successful anticoagulation in an antithrombin-deficient infant undergoing stent placement?
Case Report (n=1)
Does bivalirudin provide successful anticoagulation in an antithrombin-deficient infant undergoing stent placement?
Bivalirudin may serve as an effective alternative anticoagulant for pediatric patients with antithrombin deficiency undergoing interventional catheterization.
No takes yet. Share an insight, caveat, or question.
May support use in antithrombin-deficient infants; hypothesis-generating and should not yet change practice.
Rolando Zamora (2006) conducted a case report in Antithrombin deficiency requiring anticoagulation during stent placement (n=1). Bivalirudin was evaluated on Successful anticoagulation. Bivalirudin was successfully used as an anticoagulant in a 2-month old infant with antithrombin deficiency undergoing stent placement.